As a global company, and as a pharmaceutical company, we have a responsibility to play our part in addressing some of the world’s most pressing challenges.

Sanofi’s integrated Corporate Social Responsibility strategy aims to build a healthier, more resilient world by ensuring access to healthcare for the world’s poorest people and focus to address broader unmet needs. Integrated within the company’s “Play to Win” business strategy, Sanofi’s commitment to society is based on four essential pillars in which Sanofi is uniquely positioned to make a difference and have a greater impact: Affordable Access, R&D for Unmet Needs, Planet Care, and In and Beyond the Workplace.

Affordable Access

We commit to ensure global access & affordability to health while helping healthcare systems' sustainability.

Caption: Dr Ariany Widiastuty examines Salim at Penyengat Olak Public Health Center in Jambi Province, Indonesia

Global Health Unit (GHU)

Our autonomous, non-profit business unit to provide access to essential medicines in 40 lower-income countries.

Rare Disease Humanitarian Program

We help patients living with rare diseases who have no access to treatments, through annual donations of 100,000 vials of medicine. 

Global Access Plan

We are developing a global access plan for all new products, to make them available within two years of launch in countries where we can have an impact for patients.

More to come

R&D for Unmet Needs

We provide innovative vaccines and medicines to eradicate polio, eliminate sleeping sickness and we aim to reduce childhood cancer deaths.

Caption: Guy, 12 with his father, is the first child to receive an innovative oral treatment for sleeping sickness, in his hometown Mushie in the Democratic Republic of Congo


For 40 years, Sanofi has supplied billions of polio vaccine doses worldwide. Today the end of polio is in sight. 

Sleeping Sickness

For 21 years, we’ve partnered with the WHO to combat sleeping sickness, and we are committed to eliminating it by 2030. Sanofi is the only pharma company continuing to develop innovative medicine to eliminate the disease.

Childhood Cancers

Cancer is the leading cause of death by disease among children and our R&D teams work to develop innovative medicines for pediatric cancer.

More to come

Planet Care

We continue to minimize the potential environmental impacts of our activities and products throughout their life cycle 

Caption: A clean-up operation on Garrarus beach by Sanofi employees, Waterford – Ireland

Carbon Neutrality

Sanofi is committed to reach carbon neutrality across all operations and the entire value chain by 2030.


Sanofi will have an eco-design approach for all new products by 2025.

Blister-free Packaging

We will remove all pre-formed plastic packaging (blister packs) for syringe vaccines by 2027.

Sanofi receives Sustainable Market Initiative’s (SMI) Terra Carta Seal award for leadership in ESG

On January 11, 2023, Sanofi was awarded the Sustainable Market Initiative’s Terra Carta Seal for its leadership in ESG.

Sandrine Bouttier-Stref, Global Head of CSR, Corporate Affairs

“As the challenges facing society continue to evolve in complexity, our renewed commitment to build a healthier and more resilient world remains unwavering. Our CSR pillars are fully aligned with our “Play to Win” business strategy, empowering us to focus our efforts on the issues where we can truly have a sustainable impact for the most vulnerable populations and the planet. We are honored that our efforts to help create a healthier future for the world, the communities we serve and our employees are being recognized with the SMI Terra Carta Seal award.”

Sandrine Bouttier-Stref, Global Head of CSR, Corporate Affairs

Launched at COP26 by The Sustainable Markets Initiative, the Terra Carta Seal recognizes global companies which are driving innovation and demonstrating their commitment to, and momentum towards, the creation of genuinely sustainable markets. The Terra Carta Seal embodies the vision and ambition of His Majesty King Charles III and serves as the mandate for the SMI, providing a practical roadmap for acceleration towards an ambitious and sustainable future; one that will harness the power of Nature combined with the transformative power, innovation, and resources of the private sector.

At Sanofi, we are focused on building a healthier, more resilient world through different initiatives such as:

  • ensuring access to healthcare for the most underserved communities and bringing focus to address broader unmet needs;
  • accelerating our goal of reducing the environmental impact of our products and of our worldwide operations;
  • building a diverse and inclusive workplace.

These are some example initiatives:

  • Our Global Health Unit (GHU), a non-profit business model that operates in some of the least developed regions of the world, offers 30 of our essential medicines including treatments for cardiovascular diseases, diabetes, cancer, malaria and tuberculosis to local populations;
  • We continue to contribute to the efforts led by the World Health Organization (WHO) to eradicate polio and eliminate sleeping sickness, two diseases that afflict marginalized and vulnerable communities, with vaccines and new therapeutics;
  • We have committed to reach carbon neutrality by 2030 for Scopes 1, 2 and 3 and net zero by 2045;
  • We have pledged to reach equal representation of women and men among our senior leaders by 2025 and achieve 40% representation of women in our Executives population by 2025.

Our ambitions are high and we will continue to build momentum to create a sustainable impact.

In and Beyond the Workplace

Building an inclusive workplace while engaging with communities. 

Caption: Camille Cottin, Environmental Generalist-Ecotoxicology Specialist, with Guilhem Rousselet, Global Packaging Platform, Deguene Ly, Support Business Global External Manufacturing, and Philippe Nicolas, Change Program Coordinator, France

Diverse Senior Leadership

Sanofi is committed to building representative leadership to reflect the diversity of the communities we live and work in.

Social & Economic Engagement in Communities

Sanofi is fostering inclusion and sustainability in the local ecosystems in which it operates. 

From Leaders to Citizens

We are embedding CSR in the career development path of our leaders. 

More to come

Responsible Business

We actively participate in healthcare systems around the world. At Sanofi, we believe that this gives us the responsibility to respect the highest standards of ethics and integrity as well as conducting business in a responsible and sustainable way.

To learn more – find additional examples below

Environmental Social and Governance (ESG) Performance

Thanks to our collective efforts, our ESG performance is improving across all the ratings categories. Sanofi was recognized in 2022 as one of the most sustainability-committed companies in an ESG Evaluation performed by Standard & Poor’s Global Ratings (S&P).

Rating agencies

#WeCanDoMore to Change Lives

Learn about Sanofi’s commitment to do more! 

An interview with Lise Kingo, Independent Board Director at Sanofi, and former CEO of the UN Global Compact, the world’s largest corporate sustainability initiative

Explore more

Our contribution to the UN SDGs

Our Integrated Report 2021

2021 Declaration of Extra-Financial Performance